Peak Financial Advisors LLC Pfizer Inc Transaction History

Peak Financial Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 12, 2023	BUY	$41.75 - $54.5 $201,861 - $263,507	4,835 New	4,835 $248 Million
Q2 2022 Jul 14, 2022	SELL	$46.53 - $55.17 $499,546 - $592,305	-10,736 Reduced 72.88%	3,996 $210,000
Q1 2022 Apr 22, 2022	SELL	$45.75 - $56.69 $13,679 - $16,950	-299 Reduced 1.99%	14,732 $763,000
Q4 2021 Jan 19, 2022	BUY	$41.32 - $61.25 $157,553 - $233,546	3,813 Added 33.99%	15,031 $888,000
Q3 2021 Oct 12, 2021	BUY	$39.25 - $50.42 $440,306 - $565,611	11,218 New	11,218 $482,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Peak Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Peak Financial Advisors LLC with notifications on news.